- Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms
-
Saad F, Doros G, Haider KS, Haider A
- KMID: 2424295
- Investig Clin Urol.
- 2018 Nov;59(6):399-409.
- doi: 10.4111/icu.2018.59.6.399
PURPOSE: To analyze data from an observational, prospective, cumulative registry study in 805 hypogonadal men stratified by mild or moderate-to-severe lower urinary tract symptoms (LUTS) according to International Prostate Symptom... -
- CITED
-
- Close
- SHARE
-
- Close
- Carbon Fiber-Reinforced Polyetheretherketone Spinal Implants for Treatment of Spinal Tumors: Perceived Advantages and Limitations
-
Alvarez-Breckenridge C, Almeida Rd, Haider A, Muir M, Bird J, North R, Rhines L, Tatsui C
- KMID: 2540895
- Neurospine.
- 2023 Mar;20(1):317-326.
- doi: 10.14245/ns.2244920.460
Purpose: Carbon-fiber reinforced polyetheretherketone (CFRP)-based spinal implants are an alternative to titanium, offering less image artifact as their metallic counterparts while maintaining similar biomechanical and biocompatibility properties. Its use in... -
- CITED
-
- Close
- SHARE
-
- Close
- Psychosocial Factors and Psychological Adjustment Among Adolescents and Young Adults: A Comparative Analysis of Occasional Drug Craving and Non-Craving
-
Nida A, Haider A, Zhang XY
- KMID: 2559026
- Psychiatry Investig.
- 2024 Sep;21(9):947-957.
- doi: 10.30773/pi.2024.0124
Objective The rate of drug craving not only in Pakistan is escalating rapidly, but also from a wide range of cultures and geographically have been impacted by the drug problem.... -
- CITED
-
- Close
- SHARE
-
- Close
- Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men
-
Saad F, Yassin A, Haider A, Doros G, Gooren L
- KMID: 2155307
- Korean J Urol.
- 2015 Apr;56(4):310-317.
- doi: 10.4111/kju.2015.56.4.310
PURPOSE: To investigate the potential benefits of testosterone administration to elderly men (>65 years) with late-onset hypogonadism (LOH) in comparison with younger men and to assess the safety of testosterone... -
- CITED
-
- Close
- SHARE
-
- Close
